NovoCare® provides support for you and your patients
Once a PEF is submitted, your patient is assigned a case manager who ensures proper paperwork and documentation are submitted. They are the go-to experts to help understand the range of services offered including:
Benefit verification
Health care professionals (HCPs) can request a benefit verification by completing the PEF and sending it to NovoCare®.
Live support for patients
Once a PEF is submitted to NovoCare®, every patient is assigned a dedicated Patient Liaison.a They will be the patient’s primary contact for support throughout their treatment journey.
Prior authorization (PA) assistance
This assistance helps you and your patients navigate the insurance process by obtaining payer requirements for the PA process.
Appeals assistance
Should a patient’s insurance deny coverage, NovoCare® can assist by providing support and information about the appeals process.
JumpStart™
Provides limited free product to eligible patients who are experiencing a gap or delay in getting insurance coverage.
Eligibility and restrictions apply. Call NovoCare® at 1-844-906-5099 to see if you are eligible.
Co-pay assistance
A savings offer provides financial assistance to eligible patients.
Injection training
Professionalsa will provide live, in-person, or virtual injection training.
Patient Assistance Program (PAP)
This program will support eligible patients prescribed Novo Nordisk medications, free of charge.
aPatient Liaisons and injection trainers have a background in nursing. They are working on behalf of Novo Nordisk, the pharmaceutical company. Their role is to provide injection training and support. They are not acting as health care providers. Patients and caregivers must speak with their health care provider for any questions regarding medical care or advice.
Need assistance?
Call NovoCare® at 1-844-906-5099 8:00 AM-8:00 PM ET, Monday-Friday.
Help patients save
If your patients have commercial insurance, such as insurance they receive through an employer, they may be eligible to pay as little as $0 per fill of Rivfloza® (with annual maximum cap of $15,000).
Have questions about Rivfloza®? Reach out to our team of representatives
Important Safety Information for Rivfloza®
Adverse Reactions
Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.
Indication and Usage
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Please click here for Rivfloza® Prescribing Information.
Important Safety Information for Rivfloza®
Adverse Reactions
Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.
Indication and Usage
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Please click here for Rivfloza® Prescribing Information.